STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Diamyd Medical AB (NASDAQ:DMYDY) (STO:DIAMB):
September 1, 2007 – November 30, 2007
• The Diamyd® diabetes drug received worldwide recognition as NIDDK executed a Clinical Trial Agreement with Diamyd Medical in November 2007, for a multi-center study in recent onset type 1 diabetes patients.
